Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

SNDL Inc.

Aurora Cannabis

Canopy Growth

HEXO Corp

OrganiGram Holdings Inc.

Tilray Brands

Tuesday, October 17, 2023 marks five years since recreational cannabis was legalized in Canada and it's been tough going for operators in the budding sector. Industry players have had to contend with oversaturation, competition from the black market, limited opportunities to enter the United States market, and, more recently, challenging broader economic conditions due to high inflation and interest rates.

Cannabis stocks struggle as Canada marks five years of legal recreational use

As we enter the fourth quarter of 2023, investors looking for possibilities in the rapidly growing global cannabis market continue to focus on Canadian marijuana stocks. The cannabis sector has expanded significantly in recent years as more and more nations legalize cannabis for recreational use, including Canada. According to Grand View Research, the worldwide cannabis market is predicted to reach $103.9 billion by 2024, poised for an accelerated expansion. Specifically, Canadian marijuana stocks continue to be in high demand in this developing industry, making it crucial for investors to use short-term trading tactics and technical analysis while keeping a close eye on risk management to maximize their gains.

Q4 Potential: Best Canadian Marijuana Stocks for Mid-October

Marijuana stock investors are keeping their eyes open for a chance to take profits. For some time the level of volatile trading has made it tough to do so. Although it has its pros and cons there has been a lack of upward trading. From this, it has left many more traders with concerns about future trading. Yet some see this as a means to prepare for the future as the cannabis industry is still developing. More companies are working to expand the industry and keep things moving in the right direction.

3 Marijuana Stocks To Buy In October 2023

Abeona Therapeutics

Matterport

Nordic American Tankers

Origin Materials

Overseas Shipholding Group

Unicycive Therapeutics

Investing in undervalued penny stocks is always going to be about the same few things. Most investors are attempting to find cheap, short-term plays with reasonable catalysts in their favor.

The 7 Most Undervalued Penny Stocks to Buy in October 2023

If you're a true contrarian, you should look at cannabis stocks in 2023. A premier player in this abandoned stock sector is Cronos (NASDAQ: CRON ).

Ride the Medical Marijuana Boom Higher With Cronos Stock

TORONTO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is pleased to announce its Spinach® brand won “Best Pre-Roll” at the Grow Up Awards this past Sunday for its Spinach® Fully Charged Atomic GMO infused pre-rolls. The annual Grow Up Awards celebrate excellence in the cannabis industry, recognizing outstanding achievements and innovation in a variety of cannabis-related categories.

Cronos brand Spinach® Wins Best Pre-Roll at Grow Up Awards

Curaleaf Holdings, Inc.

Unsurprisingly, the current year has been depressing for cannabis stocks. Regulatory headwinds continue to play spoilsport and making stock predictions somewhat difficult.

3 Cannabis Stocks Looking Hot Heading Into 2024

Green Thumb Industries Inc.

Cannabis stocks are benefitting from a resurgence of interest as it becomes increasingly likely that it will be rescheduled legally. Less stringent legal codes will open up new opportunities, especially tax benefits, to cannabis companies.

Buy This, Not That: 2 Cannabis Stocks to Own, 1 to Avoid

AdvisorShares Pure US Cannabis ETF

Roundhill Cannabis ETF

Shares of marijuana companies gave back early gains on Wednesday after jumping following a U.S. Senate committee voted to advance a bill that would give legal cannabis-related companies a boost by allowing them to access banking system services.

Cannabis stock gains fade in volatile trading on US Senate bill hopes

Cannabis stocks have navigated an extended period of uncertainty and financial depression thanks to regulatory headwinds. Further, most cannabis companies have witnessed an extended period of cash burn.

Hidden Gems: 3 Cannabis Stocks Flying Under the Radar

Marijuana stock investors are keeping focused on the future of the cannabis industry. Right now even with an increase in volatile trading, the industry is still progressing. There are more states and global regions that are working to establish legal cannabis markets. It seems that the toughest hurdle to get passed is cannabis reform whether it's the state level or federal. Although federal reform is what some are calling the last true obstacle of the sector. Now for the US cannabis industry, this holds more truth than not.

Best Cannabis & Marijuana Stocks For Q3 2023

Bitfarms Ltd

Polestar Automotive Holding UK PLC

The market year-to-date has been rewarding after the big correction witnessed last year. There are several growth and penny stocks that have bounced back strongly after being decimated last year.

3 Penny Stocks That Can Still Double Before the End of 2023

Bausch Health Companies Inc

GrowGeneration Corp

Jazz Pharmaceuticals

Scotts Miracle-Gro

There's a reason people are looking for cannabis stocks to buy now. It is increasingly likely that marijuana will be rescheduled from a Schedule I controlled substance to a Schedule III controlled substance.

7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom

The U.S.-listed shares of Cronos Group Inc. CRON, -3.24% CRON, -3.56% climbed 2.5% in premarket trading Monday, after the Toronto-based cannabis company said it launched its Peace Naturals medical brand in Germany. The company has signed a distribution agreement with Cansativa Group, which has a network of about 2,000 pharmacies in Germany.

Cronos stock climbs after launching Peace Naturals medical cannabis brand in Germany

TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with Cansativa Group (“Cansativa”), one of the leading distributors of medical cannabis in Germany. Cansativa is a market leader in the medical cannabis market and is a driving force in the German cannabis industry. Cansativa has a network of approximately 2,000 pharmacies domestically; they currently supply around 300,000 patients in Germany's medical market.

Cronos launches leading medical brand PEACE NATURALS® in Germany

Borr Drilling Ltd

ChargePoint Holdings

EHang Holdings Ltd - ADR

Piedmont Lithium

Riot Blockchain

Solid Power

I believe that it's a good time to accumulate some undervalued small-cap stocks. The S&P 500 index should have a sustained rally next year.

The 7 Most Undervalued Small-Cap Stocks to Buy in September 2023

The House of Representatives is set to meet to discuss several pot-related measures this week. The march toward full U.S. legalization continues to gather pace.

Why Marijuana Stocks Triumphed on Monday

Marijuana penny stocks and higher-priced cannabis stocks are having a moment in the stock market right now. Mainstream stock market news is about inflation being high, and considered a negative.

Marijuana Penny Stocks Are On Fire, 3 To Watch Right Now

The global buzz around medical cannabis stocks just got a whole lot louder. The corridors of the U.S. health sector are abuzz with the federal Health and Human Services Department urging the government to re-evaluate its hard stance on marijuana effectively.

3 Medical Cannabis Stocks Poised for Global Growth

Easterly Government Properties

Harte Hanks

Philip Morris

Constellation Brands

Stocks that deal in cannabis are rising as the U.S. government moves toward re-classifying marijuana. The Department of Health and Human Services (HHS) has asked the Drug Enforcement Administration (DEA) to consider moving marijuana from Schedule I to Schedule III.

Why Are Cannabis Stocks Still Up Today?

Innovative Industrial Properties

Chicago Atlantic Real Estate Finance

Curaleaf Holdings Inc. OTCMKTS: CURLF,  Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Human Services recommended that marijuana no longer be classified as a Schedule 1 drug.

Will This New Development Mean A Big Rally In Cannabis Stocks?

Cannabis stocks have come roaring back on recent news of major decriminalization progress at the federal level. The big question now for anyone who owns marijuana stocks or is considering the sector: Is there more upside left?

Cannabis stocks are still a buy despite recent double-digit gains

Trulieve Cannabis Corp.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

The cannabis industry is still evolving and has had its fair share of ups and downs. There has been an ongoing battle to establish better laws and regulations. Right now many legal states are facing concerns of high state taxes and other regulatory concerns. This has made it tough not just to invest but also to see sustainable market momentum. Still, there is a lot to look forward to as overall progress continues for the industry.

3 Marijuana Stocks To Buy In September?

De facto U.S. marijuana legalization on the Federal level could be coming sooner than many think. A top official at the Department of Health and Human Services has requested that pot be rescheduled as a far less dangerous drug.

Why Investors Were so High on Cronos Stock This Week

News for Cronos Group Stock (CRON)